1. Shankland KR, Armitage JO, Hancock BW . Non-Hodgkin lymphoma. Lancet 2012; 380: 848–857.
2. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. International Agency for Research on Cancer: Lyon, France, 2013.
3. Engholm G, Ferlay J, Christensen N, Johannesen T, Khan S, Køtlum JE et al. NORDCAN: Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries, 25.04.2014 ed. Association of the Nordic Cancer Registries. Danish Cancer Society: Copenhagen, Denmark, 2014.
4. Fallah M, Liu X, Ji J, Forsti A, Sundquist K, Hemminki K . Autoimmune diseases associated with non-Hodgkin lymphoma: a nationwide cohort study. Ann Oncol 2014; 25: 2025–2030.
5. Hemminki K, Li X, Forsti A, Sundquist J, Sundquist K . Non-Hodgkin lymphoma in familial amyloid polyneuropathy patients in Sweden. Blood 2013; 122: 458–459.